Heme-oxygenase-1 (HO-1) in CCR2/CCL2/CD200 brain mononuclear cells contribute to neuroinflammation in young adulthood after chorioamnionitis

The brain is not a sealed fortress; it is a living organ that constantly communicates with the rest of the body, including the immune system. When the body faces a threat, immune cells travel through the bloodstream to investigate and repair damage. In a healthy brain, these visitors are kept in check by a set of signals that tell them when to work and when to stand down. One such signal is a molecule called CD200, which acts like a "stop" sign for immune cells, preventing them from becoming overactive and causing harm. Another signal involves a receptor called CCR2, which acts like a "welcome" sign, inviting specific immune cells to enter the brain when they are needed to fight infection or clear debris. A third player is an enzyme called heme-oxygenase-1, or HO-1. This molecule helps cells manage stress and repair damage, but its role is delicate: too little leaves cells vulnerable, while too much can actually fuel inflammation and oxidative stress, a state where cells are damaged by unstable molecules.

Sometimes, this delicate balance is disrupted before a baby is even born. A condition called chorioamnionitis occurs when the membranes surrounding the fetus become inflamed, often due to an infection. This exposure to inflammation in the womb can have lasting effects, leading to brain injuries that do not show up until years later. Scientists have long known that this early inflammation causes problems, but they have not fully understood how the immune cells in the brain change over time to keep the inflammation going long after the initial infection has cleared. The question remains: do these cells simply return to normal, or do they carry a hidden, altered state into adulthood that continues to damage the brain?

A team of researchers at Johns Hopkins University School of Medicine set out to answer this question by looking at the brains of rats that had been exposed to this type of prenatal inflammation. They wanted to see how the immune cells in the brain changed from early life into young adulthood. To do this, they created a model of chorioamnionitis in pregnant rats by temporarily restricting blood flow and introducing a harmless bacterial component to the womb, mimicking the stress of an infection. They then waited for the offspring to grow up, collecting brain tissue at two specific times: when the rats were young adults, about three weeks old, and again when they were fully grown, about two months old. At each stage, the researchers carefully separated the immune cells from the brain tissue and used a high-tech microscope to count them and measure the levels of specific markers on their surfaces and inside them. They looked specifically for the presence of the "welcome" and "stop" signals, as well as the levels of the stress-management enzyme HO-1.

The researchers found that the immune landscape of the brain was not static; it changed dramatically as the rats aged, and the history of prenatal inflammation left a permanent mark on this process. In the young rats, the immune cells behaved in a way that suggested they were in a state of active, aggressive inflammation. However, by the time the rats reached young adulthood, the nature of the inflammation had shifted. The cells were no longer just fighting an infection; they were stuck in a state of high oxidative stress. The most striking discovery was that the levels of HO-1, the stress-management enzyme, were significantly higher in the brains of the adult rats that had been exposed to prenatal inflammation compared to those that had not. This increase was not uniform; it was concentrated in specific types of immune cells that had entered the brain from the bloodstream.

In the adult brains of the rats with a history of prenatal inflammation, the researchers observed a distinct shift in the balance of immune signals. The number of cells carrying the "welcome" signal, CCR2, had decreased, while the number of cells carrying the "stop" signal, CD200, had increased relative to the CCR2 cells. This change in ratio suggested that the brain's immune environment had become dysregulated. The cells were not responding to signals in a normal, balanced way. Instead, they appeared to be locked in a cycle where the immune system was trying to repair damage but was simultaneously generating more stress. The high levels of HO-1 in these cells indicated that the cells were under significant oxidative pressure, a condition that can damage brain tissue over time.

The study also revealed that the type of immune cells present in the brain changed over time. In the young rats, the cells were more similar to those that fight infection directly. By adulthood, the population had shifted toward cells that are associated with oxidative stress and tissue damage. The researchers noted that the cells that had entered the brain from the bloodstream were the ones showing the most dramatic changes in their internal stress levels. This suggests that the prenatal inflammation did not just cause a temporary reaction; it altered the very identity of the immune cells that settled in the brain, priming them to cause harm long after the initial event.

One of the key findings was that the levels of a chemical messenger called CCL2, which usually attracts immune cells to the brain, remained high in the blood but did not necessarily increase inside the brain cells themselves. This disconnect suggested that the brain was constantly receiving a signal to recruit more immune cells from the body, creating a gradient that kept the brain in a state of alert. The researchers found that the ratio of this messenger to its receptor was higher in the adult brains of the inflamed group, reinforcing the idea that the brain was stuck in a loop of trying to manage an inflammation that never fully resolved.

The researchers concluded that the brain's immune system does not simply recover from prenatal inflammation; it undergoes a permanent transformation. The cells that survive the early insult change their behavior as the animal ages, moving from a state of active inflammation to a state of chronic oxidative stress. This shift is marked by a surge in the stress-management enzyme HO-1, which, in this context, appears to be a sign of distress rather than protection. The study suggests that this altered state of the immune cells could be a key reason why people who experienced prenatal inflammation are at higher risk for neurological problems later in life, such as cognitive deficits or movement disorders.

This work provides a clearer picture of how early-life events can echo into adulthood. It shows that the brain's immune cells are not just passive observers but active participants in long-term health. When these cells are altered by early stress, they can become a source of ongoing damage, quietly eroding brain function over years. The findings highlight the importance of understanding the immune system's role in brain development and suggest that targeting these specific immune pathways might one day offer a way to prevent or treat the long-term consequences of prenatal inflammation. The research does not claim to have found a cure, but it has identified a specific mechanism that keeps the brain in a state of low-level distress, offering a new target for future investigation.